Aptose Biosciences Inc.

TSX:APS Stock Report

Market Cap: CA$18.7m

Aptose Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

TSX:APS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 Nov 24BuyCA$27,995William RiceIndividual100,000CA$0.28
25 Nov 24BuyCA$27,995William RiceIndividual100,000CA$0.28
31 Jan 24BuyCA$5,351,560Hanmi Pharm. Co., Ltd.Company2,105,263CA$2.54

Insider Trading Volume

Insider Buying: APS insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of APS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders69,5400.117%
Public Companies2,989,4155.02%
Institutions3,299,7125.54%
General Public53,162,51689.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 649.4%.

Top Shareholders

Top 25 shareholders own 10.68% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.02%
Hanmi Pharm. Co., Ltd.
2,989,415CA$941.7k0%no data
3.28%
Armistice Capital LLC
1,955,202CA$615.9k14.1%0.01%
1%
DRW Trading Group, Asset Management Arm
592,829CA$186.7k0%0.01%
0.67%
Sigma Planning Corporation
401,750CA$126.6k71.3%no data
0.22%
UBS Asset Management AG
133,476CA$42.0k0%no data
0.13%
Nantahala Capital Management, LLC
77,340CA$24.4k0%no data
0.057%
Erich Platzer
33,666CA$10.6k0%no data
0.053%
Morgan Stanley, Investment Banking and Brokerage Investments
31,353CA$9.9k3.27%no data
0.051%
Two Sigma Securities, LLC, Asset Management Arm
30,427CA$9.6k0%no data
0.045%
Annandale Capital, LLC
26,666CA$8.4k0%no data
0.032%
Cetera Investment Advisers LLC
19,214CA$6.1k-0.12%no data
0.031%
Bernd Seizinger
18,332CA$5.8k7.84%no data
0.021%
Texas Capital Bank Wealth Management Services, Inc.
12,448CA$3.9k0%no data
0.017%
Pds Planning Inc, Asset Management Arm
10,000CA$3.1k0%no data
0.012%
Rafael Bejar
7,333CA$2.3k0%no data
0.012%
Fletcher Payne
7,332CA$2.3k0%no data
0.0034%
U.S. Bancorp Asset Management, Inc.
2,020CA$635.60%no data
0.0024%
Denis Burger
1,444CA$455.60%no data
0.0024%
RBC Dominion Securities Inc., Asset Management Arm
1,401CA$440.6-36.9%no data
0.0022%
Dimensional Fund Advisors LP
1,295CA$408.7-37.2%no data
0.002%
The Gleason Group, Inc.
1,216CA$382.50%no data
0.0017%
Warren Whitehead
1,000CA$315.00%no data
0.0014%
Newbridge Financial Services Group, Inc.
832CA$262.50%no data
0.0011%
Toronto-Dominion Bank, Banking Investments
684CA$215.6-90.9%no data
0.00073%
Mark Vincent
433CA$136.90%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/12 02:24
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aptose Biosciences Inc. is covered by 10 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dylan DupuisB. Riley Securities, Inc.
John NewmanCanaccord Genuity
Joseph PantginisH.C. Wainwright & Co.